Turning the tide for CKD in T2D

You are invited to join us for a face-to-face meeting featuring the globally recognised endocrinologist, Prof Serge Jabbour (US). Commencing with a challenge to clinicians on the urgency of screening and treating CKD as part of a re-focus away from glycaemic targets to cardiorenal outcomes based treatments. Followed by an engaging presentation on the translation of DAPA-CKD evidence into Australian clinical practice and concluding with an expert panel discussion and Q&A.